1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ATLANTIC INTERNATIONAL CORP.
Atlantic International Corp. XNAS: ATLN
Download real time
2.18 0.01 (0.46%)
27.57% Fall from 52W High
27,661
XNAS Volume

XNAS 14 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Atlantic International Corp.

The latest disclosure was made by Jeffrey M. Jagid in Atlantic International Corp. where a trade of 2,885,856 Common Stock, $.0001 par value done at an average price of $0.0 was reported to US exchanges on June 23, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jeffrey M. Jagid Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jun 2025 2,885,856 3,735,169 - 0.0 289 Common Stock, $.0001 par value
Jeffrey M. Jagid Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2025 2,885,856 2,885,856 - - Restricted Stock Units
Christopher Broderick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2025 577,171 577,171 - - Restricted Stock Units
Christopher Broderick Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jun 2025 577,171 2,004,237 - 0.0 58 Common Stock, $.0001 par value
Michael Tenore General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2025 577,171 577,171 - - Restricted Stock Units
Michael Tenore General Counsel Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jun 2025 577,171 1,001,634 - 0.0 58 Common Stock, $.0001 par value
Christopher Broderick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2025 577,171 577,171 - - Restricted Stock Units
Christopher Broderick Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Jan 2025 577,171 2,581,408 - 0.0 58 Common Stock, $.00001 par value
Michael Tenore General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2025 577,171 577,171 - - Restricted Stock Units
Michael Tenore General Counsel Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Jan 2025 577,171 1,578,865 - 0.0 58 Common Stock, $.00001 par value
Jeffrey M. Jagid Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 2,885,856 2,885,856 - - Restricted Stock Units
Jeffrey M. Jagid Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 02 Jan 2025 2,885,856 6,621,025 - 0.0 289 Common Stock, $.00001 par value
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters